STAT+: Biden’s FDA pick Califf vows to reform accelerated approvals to win a key senator’s support

WASHINGTON — President Biden’s pick to lead the Food and Drug Administration promised a key senator that he will crack down on drug companies abusing the so-called accelerated approval pathway within a month of his confirmation.
Robert Califf met with Sen. Ron Wyden (D-Ore.), the chair of the Senate Finance Committee, last week, STAT first reported . In a new letter made public Friday, Wyden provides a clear summation of his discussion with the nominee. Continue to STAT+ to read the full story…